• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday

    11/2/22 5:07:52 AM ET
    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ABMD alert in real time by email

    Gainers

    • Abiomed, Inc. (NASDAQ:ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company . Also, the company reported better-than-expected Q2 adjusted EPS results.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) gained 46.6% to close at $2.83. Sonnet BioTherapeutics recently announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) gained 44% to settle at $0.74. NLS Pharmaceutics was granted FDA Orpha Drug Designation for Quilience (Mazindol) for the treatment of idiopathic hypersomnia.
    • Ucommune International Ltd (NASDAQ:UK) jumped 34.7% to close at $1.71.
    • Safe-T Group Ltd (NASDAQ:SFET) shares gained 30.7% to close at $0.3921 on Tuesday as the company said its privacy application reached over 5,000,000 downloads.
    • Aravive, Inc. (NASDAQ:ARAV) gained 30.5% to close at $1.71.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) jumped 25.1% to settle at $2.49.
    • Mill City Ventures III, Ltd. (NASDAQ:MCVT) gained 24.1% to close at $2.73.
    • IDEX Biometrics ASA (NASDAQ:IDBA) climbed 23% to close at $7.27.
    • Harsco Corporation (NYSE:HSC) climbed 22.5% to close at $6.48 after the company reported better-than-expected Q3 sales results and raised FY22 adjusted EPS guidance.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) gained 21.9% to close at $2.06.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) rose 21.2% to close at $1.05.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) surged 20.3% to settle at $2.90.
    • Humanigen, Inc. (NASDAQ:HGEN) gained 19.9% to settle at $0.1680.
    • NantHealth, Inc. (NASDAQ:NH) jumped 19.6% to close at $0.3886.
    • Tarena International, Inc. (NASDAQ:TEDU) gained 18.3% to settle at $5.49.
    • Leju Holdings Limited (NYSE:LEJU) rose 18.2% to close at $1.56.
    • IronNet, Inc. (NYSE:IRNT) gained 17.4% to close at $0.8338. IronNet announced receipt of continued listing standard notice from NYSE.
    • Pharming Group N.V. (NASDAQ:PHAR) gained 17.2% to close at $11.40.
    • Ambow Education Holding Ltd. (NYSE:AMBO) surged 16.8% to close at $0.3038.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) climbed 16.4% to close at $0.6399.
    • Atai Life Sciences N.V. (NASDAQ:ATAI) gained 14.6% to close at $3.38 after Loop Capital initiated coverage on the stock with a Buy rating and a $18 price target.
    • Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) rose 14% to settle at $59.26 after the company reported better-than-expected Q3 EPS and sales results.
    • Community Health Systems, Inc. (NYSE:CYH) gained 13.6% to close at $3.26. Community Health Systems recently posted a Q3 loss of $0.52 per share.
    • Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) jumped 13.4% to settle at $15.73 after the company reported better-than-expected Q3 sales results.
    • Carvana Co. (NYSE:CVNA) gained 12.9% to close at $15.28 after JP Morgan upgraded the stock from Underweight to Neutral and announced a $20 price target.
    • Zai Lab Limited (NASDAQ:ZLAB) shares jumped 12.3% to close at $25.02. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
    • Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) climbed 12.1% to close at $12.80 after the company posted a profit for the third quarter.
    • Uber Technologies, Inc. (NYSE:UBER) rose 12% to close at $29.75 after the company reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.
    • Kanzhun Limited (NASDAQ:BZ) jumped 11.7% to close at $12.21. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
    • H World Group Limited (NASDAQ:HTHT) shares climbed 10.8% to close at $30.00.
    • MINISO Group Holding Limited (NYSE:MNSO) rose 10.4% to close at $5.63.
    • IDEXX Laboratories, Inc. (NASDAQ:IDXX) surged 9.8% to settle at $394.93 after the company reported better-than-expected Q3 EPS and sales results.
    • RLX Technology Inc. (NYSE:RLX) rose 9.6% to close at $1.37 after declining over 7% on Monday.
    • Hologic, Inc. (NASDAQ:HOLX) rose 9.3% to close at $74.13 after the company reported better-than-expected Q3 EPS and sales results.
    • Trip.com Group Limited (NASDAQ:TCOM) shares gained 8.4% to settle at $24.54 amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
    • Lattice Semiconductor Corporation (NASDAQ:LSCC) gained 8.4% to close at $52.58 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 sales guidance above analyst estimates.
    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) climbed 7.8% to close at $1.11. Wells Fargo recently upgraded the stock from Equal-Weight to Overweight and raised its price target from $1.5 to $2.
    • Cyxtera Technologies, Inc. (NASDAQ:CYXT) gained 6.6% to close at $2.58.
    • Blucora, Inc. (NASDAQ:BCOR) gained 6.1% to close at $23.37 after the company reported better-than-expected Q3 sales results and announced it sold TaxAct for $720 million in cash.
    • iQIYI, Inc. (NASDAQ:IQ) rose 5.5% to close at $2.13. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
    • SoFi Technologies, Inc. (NASDAQ:SOFI) gained 5.3% to close at $5.73 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 revenue guidance.
    • Lyft, Inc. (NASDAQ:LYFT) gained 3.5% to close at $15.15 in sympathy with Uber, which reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.

     


    Losers

    • Varonis Systems, Inc. (NASDAQ:VRNS) shares fell 35.5% to close at $17.27 on Tuesday after the company reported worse-than-expected Q3 results.
    • Satixfy Communications Ltd. (NYSE:SATX) dipped 29.4% to close at $11.51.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) fell 27.4% to settle at $1.14.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares fell 25.2% to close at $0.8001 after jumping over 63% on Monday.
    • Catalent, Inc. (NYSE:CTLT) fell 24.7% to close at $49.53 after the company reported worse-than-expected Q1 EPS and sales results and issued FY23 sales guidance below estimates.
    • Selina Hospitality PLC (NASDAQ:SLNA) fell 22.9% to close at $9.94.
    • LMF Acquisition Opportunities, Inc. (NASDAQ:ICU) fell 22.1% to close at $8.48.
    • Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) dropped 21.4% to close at $5.11. Coeptis Therapeutics announced closing of business combination with Bull Horn Holdings Corp.
    • Instil Bio, Inc. (NASDAQ:TIL) fell 20.3% to settle at $2.63. Instil Bio voluntarily paused enrollment of its ongoing clinical trials. Cowen & Co. downgraded Instil Bio from Outperform to Market Perform.
    • Solaris Oilfield Infrastructure, Inc. (NYSE:SOI) fell 19.8% to settle at $10.92 following downbeat quarterly sales.
    • Vyant Bio, Inc. (NASDAQ:VYNT) fell 18.8% to close at $0.3799 after the company announced a one-for-five reverse stock split.
    • Starry Group Holdings, Inc. (NYSE:STRY) dropped 18.6% to close at $0.18. Citigroup recently downgraded the stock from Neutral to Sell and lowered its price target from $3.75 to $0.25.
    • TETRA Technologies, Inc. (NYSE:TTI) declined 18.2% to close at $4.04 following weak quarterly results.
    • Argo Blockchain plc (NASDAQ:ARBK) declined 18% to close at $0.9099. Argo Blockchain shares dipped around 44% on Monday after the company announced it believes its previously announced non-binding LOI with a strategic investor to raise $27 million via a subscription for ordinary shares will no longer be conssumated.
    • Perfect Corp. (NYSE:PERF) dropped 17.9% to settle at $9.02.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) fell 17.3% to close at $2.35.
    • Clearwater Paper Corporation (NYSE:CLW) declined 16.8% to close at $37.00 following Q3 results. RBC Capital downgraded Clearwater Paper from Outperform to Sector Perform.
    • Zebra Technologies Corporation (NASDAQ:ZBRA) dropped 15.9% to close at $238.30 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS guidance below analyst estimates.
    • Myriad Genetics, Inc. (NASDAQ:MYGN) fell 15.6% to close at $17.50 following downbeat Q3 results.
    • The Goodyear Tire & Rubber Company (NASDAQ:GT) fell 14.9% to close at $10.81 after the company reported worse-than-expected Q3 earnings.
    • Transcat, Inc. (NASDAQ:TRNS) dropped 12.8% to close at $72.13 following Q2 results.
    • Paragon 28, Inc. (NYSE:FNA) fell 12.8% to close at $17.41. Paragon 28 filed for mixed shelf of up to $100 million.
    • Uxin Limited (NASDAQ:UXIN) dropped 12.6% to close at $3.60.
    • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) fell 11.2% to close at $11.86 after the company reported Q3 earnings results and issued FY22 guidance.
    • OrthoPediatrics Corp. (NASDAQ:KIDS) fell 10.7% to close at $37.96 after the company issued FY22 revenue guidance below estimates.
    • Nikola Corporation (NASDAQ:NKLA) declined 10.3% to settle at $3.40. Nikola recently announced a hydrogen supply collaboration with Keystate.
    • Harmonic Inc. (NASDAQ:HLIT) dropped 10.2% to close at $13.88 following Q3 results.
    • SeqLL Inc. (NASDAQ:SQL) fell 10.1% to close at $0.5290.
    • Evolent Health, Inc. (NYSE:EVH) declined 9.1% to close at $28.93. Truist Securities initiated coverage on Evolent Health with a Hold rating and announced a price target of $33.
    • Ecolab Inc. (NYSE:ECL) dropped 9% to close at $142.98 after the company reported worse-than-expected Q3 EPS results.
    • TopBuild Corp. (NYSE:BLD) dropped 7.6% to close at $157.18 following Q3 results.
    • Kforce Inc. (NASDAQ:KFRC) fell 7.5% to close at $58.53 after reporting Q3 results.
    • Avis Budget Group, Inc. (NASDAQ:CAR) fell 6.7% to close at $220.52 following Q3 results.
    • Sealed Air Corporation (NYSE:SEE) dipped 6.7% to close at $44.42 after the company announced it will acquire Liquibox for $1.15 billion. The company also reported worse-than-expected Q3 sales.
    • Canopy Growth Corporation (NASDAQ:CGC) dropped 6.4% to close at $3.49.
    • Babcock & Wilcox Enterprises, Inc. (NYSE:BW) fell 4.8% to close at $4.34.
    • Stryker Corporation (NYSE:SYK) fell 4% to close at $220.09 after the company reported worse-than-expected Q3 results and issued 2022 guidance below estimates.
    Get the next $ABMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABMD
    $ACOR
    $AGLE
    $AMBO

    CompanyDatePrice TargetRatingAnalyst
    Stryker Corporation
    $SYK
    2/20/2026Outperform
    William Blair
    Kiniksa Pharmaceuticals International plc
    $KNSA
    2/19/2026$62.00Buy
    Canaccord Genuity
    BioCryst Pharmaceuticals Inc.
    $BCRX
    2/18/2026$17.00Outperform
    Evercore ISI
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/11/2026$46.00Neutral
    UBS
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    Varonis Systems Inc.
    $VRNS
    2/5/2026$30.00Neutral → Buy
    DA Davidson
    Uber Technologies Inc.
    $UBER
    2/4/2026$100.00Mkt Perform → Mkt Outperform
    Citizens JMP
    SoFi Technologies Inc.
    $SOFI
    2/3/2026$31.00Neutral → Overweight
    Analyst
    More analyst ratings

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AtaiBeckley To Host Virtual Investor Day on March 6, 2026

    NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ:ATAI) ("AtaiBeckley" or "Company"), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced that it will host a Virtual Investor Day on Friday, March 6, 2026, from 9:00 a.m. to 12:00 p.m. ET. The event will feature presentations and live Q&A sessions with members of the Company's executive leadership team and several external key opinion leaders. Investors, analysts, and members of the media are invited to register for the live webcast. A replay will be made available following the event on the investor

    2/20/26 7:00:00 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BOSS Zhipin Continues Share Repurchases: More than RMB340M in 2026 Under Buyback Program

    BEIJING, Feb. 20, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin"or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing near RMB25 million to repurchase 410,642 ordinary shares on Feb 17 and Feb 18. In 2026, the Company has deployed more than RMB340 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. BOSS Zhipin maintains authorization under its existing program to repurchase up to USD250 million worth of its shares, with the program remaining active until the end of August 2026. CONTACT: PIACENTE·FINANCIAL COMMUNICATIONS [email protected]

    2/20/26 4:00:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    Ecolab Declares Cash Dividend

    The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.73 per common share, to be paid April 15, 2026, to shareholders of record at the close of business on March 17, 2026. Ecolab has paid cash dividends on its common stock for 89 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science‑based solutions, data‑driven insights, AI technology and world‑class service. This unique combination enables Ec

    2/19/26 6:45:00 PM ET
    $ECL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, GBUL, SIPS Keough Kelli sold $184,118 worth of shares (9,755 units at $18.87), decreasing direct ownership by 3% to 293,725 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/20/26 8:29:29 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    CHIEF FINANCIAL OFFICER Kirkland Scott D covered exercise/tax liability with 3,956 shares and was granted 9,740 shares, increasing direct ownership by 50% to 17,313 units (SEC Form 4)

    4 - ECOLAB INC. (0000031462) (Issuer)

    2/20/26 4:49:52 PM ET
    $ECL
    Package Goods/Cosmetics
    Consumer Discretionary

    EVP & GM - GLOBAL PEST Hlila Alexandra M A covered exercise/tax liability with 215 shares and was granted 508 shares, increasing direct ownership by 344% to 379 units (SEC Form 4)

    4 - ECOLAB INC. (0000031462) (Issuer)

    2/20/26 4:47:15 PM ET
    $ECL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Risher John David bought $100,179 worth of shares (7,490 units at $13.38), increasing direct ownership by 0.07% to 11,481,792 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/18/26 4:10:21 PM ET
    $LYFT
    Real Estate

    CEO, President, Chairman Faitelson Yakov bought $598,907 worth of shares (26,725 units at $22.41), gifted 87,000 shares, received a gift of 78,928 shares and was granted 315,674 shares, increasing direct ownership by 14% to 2,098,387 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:31:52 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    EVP Engineering & CTO Bass David was granted 169,095 shares and bought $69,941 worth of shares (2,980 units at $23.47), increasing direct ownership by 20% to 1,042,924 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:27:11 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Stryker

    William Blair initiated coverage of Stryker with a rating of Outperform

    2/20/26 8:25:36 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Canaccord Genuity initiated coverage on Kiniksa Pharmaceuticals with a new price target

    Canaccord Genuity initiated coverage of Kiniksa Pharmaceuticals with a rating of Buy and set a new price target of $62.00

    2/19/26 7:51:41 AM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Evercore ISI resumed coverage on BioCryst Pharma with a new price target

    Evercore ISI resumed coverage of BioCryst Pharma with a rating of Outperform and set a new price target of $17.00

    2/18/26 8:21:17 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    SEC Filings

    View All

    SEC Form 10-K filed by IDEXX Laboratories Inc.

    10-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer)

    2/20/26 4:09:24 PM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 10-K filed by Kforce Inc.

    10-K - KFORCE INC (0000930420) (Filer)

    2/20/26 4:09:05 PM ET
    $KFRC
    Professional Services
    Consumer Discretionary

    SEC Form 6-K filed by KANZHUN LIMITED

    6-K - Kanzhun Ltd (0001842827) (Filer)

    2/20/26 6:07:16 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 29, 2024 - FDA Roundup: October 29, 2024

    For Immediate Release: October 29, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for mod

    10/29/24 3:30:19 PM ET
    $HOLX
    Medical Electronics
    Health Care

    February 2, 2024 - FDA Roundup: February 2, 2024

    For Immediate Release: February 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a safety communication to warn consumers, health care providers, and health care facilities not to use certain Cardinal Health Monoject luer-lock and enteral syringes. Dimensional changes made to the syringes, when used with syringe pump

    2/2/24 3:58:21 PM ET
    $HOLX
    Medical Electronics
    Health Care

    FDA Approval for OCALIVA issued to INTERCEPT PHARMS INC

    Submission status for INTERCEPT PHARMS INC's drug OCALIVA (SUPPL-8) with active ingredient OBETICHOLIC ACID has changed to 'Approval' on 02/24/2022. Application Category: NDA, Application Number: 207999, Application Classification: Labeling

    2/25/22 4:36:46 AM ET
    $ICPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Financials

    Live finance-specific insights

    View All

    Ecolab Declares Cash Dividend

    The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.73 per common share, to be paid April 15, 2026, to shareholders of record at the close of business on March 17, 2026. Ecolab has paid cash dividends on its common stock for 89 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science‑based solutions, data‑driven insights, AI technology and world‑class service. This unique combination enables Ec

    2/19/26 6:45:00 PM ET
    $ECL
    Package Goods/Cosmetics
    Consumer Discretionary

    Harmonic Announces Fourth Quarter and Fiscal 2025 Results

    Record quarterly Broadband bookings drove a 3.5 book-to-bill in Q4Previously announced sale of Video business proceeding as anticipatedSAN JOSE, Calif., Feb. 19, 2026 /PRNewswire/ -- Harmonic Inc. (NASDAQ:HLIT) today announced its unaudited results for the fourth quarter and fiscal year ended December 31, 2025. "We ended the year with extremely strong quarterly bookings across our Broadband business," said Nimrod Ben-Natan, president and chief executive officer of Harmonic. "These bookings drove a 3.5 book-to-bill for the quarter and a substantial year-over-year increase in back

    2/19/26 4:05:00 PM ET
    $HLIT
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    LONDON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 24, 2026 at 8:30 a.m. Eastern Time to report its fourth quarter and full year 2025 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique p

    2/19/26 4:01:00 PM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Leadership Updates

    Live Leadership Updates

    View All

    AtaiBeckley Appoints Michael Faerm as Chief Financial Officer

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc (NASDAQ:ATAI) ("AtaiBeckley" or the "Company"), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026. Mr. Faerm is a seasoned financial executive with more than 25 years of experience across life sciences companies, equity research, and investment banking. As Chief Financial Officer at AtaiBeckley, he will lead the Company's financial strategy, capital markets activities, and overall financial operations. Anne Johnson, who ha

    2/19/26 7:00:00 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Babcock & Wilcox Enterprises, Inc. Appoints Dr. Homaira Akbari (Ph.D.) to Board of Directors

    Babcock & Wilcox Enterprises, Inc. (B&W) (NYSE:BW) announced today that Dr. Homaira Akbari (Ph.D.) has been appointed to its Board of Directors, bringing the total to seven members. Dr. Akbari has served on the Board of Directors of over 25 public and private companies, including Veolia Group, a global leader in waste to energy, environmentals and hazardous waste facilities, and Banco Santander (NYSE:SAN). Dr. Akbari brings extensive international leadership experience across medium and large technology companies, including in the energy and finance sectors. She has held senior management roles in Fortune 1000 companies including Microsoft, Thales and Liberty Media, and served as member

    1/27/26 4:30:00 PM ET
    $BW
    $SAN
    Building Products
    Industrials
    Commercial Banks
    Finance

    Water.org Partners with Gap Inc., Amazon, Starbucks, and Ecolab to Launch Get Blue™, Advancing Water.org's Goal of Reaching 200 Million People by 2030

    Founding partners will activate products, content, and experiences that help fund access to safe water and sanitation through Water.org's proven solutions DAVOS, Switzerland, Jan. 19, 2026 /PRNewswire/ -- Water.org, Gap Inc., Amazon, Starbucks, and Ecolab today announced the launch of Get Blue™. The global initiative is designed to accelerate access to safe water and sanitation by aligning business leadership, consumer engagement, and capital behind Water.org's proven, market-driven solutions, reaching families and communities in need around the world. Today, 2.1 billion peopl

    1/19/26 2:00:00 AM ET
    $ECL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ABMD
    $ACOR
    $AGLE
    $AMBO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care